A LinkedIn post from Doccla highlights a new partnership with Guy’s and St Thomas’ NHS Foundation Trust and the North Lambeth Primary Care Network to support patients with chronic obstructive pulmonary disease, or COPD. The initiative centers on a Proactive Care service deployed across six GP practices in North Lambeth, aiming to intervene earlier and reduce hospital admissions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, the service can support up to 150 patients at a time with regular symptom reviews, home-based remote monitoring and personalised guidance from clinical teams. The post suggests that Doccla’s technology is used to surface early warning signals, enabling clinicians to act sooner and potentially keeping more patients well at home.
The message cites commentary from a senior clinical leader at Guy’s and St Thomas’ indicating an ambition to shift more specialist support into community settings, which implies growing institutional interest in remote and neighbourhood-based care models. For investors, this collaboration may signal strengthening traction for Doccla within the U.K. National Health Service, enhancing its reference base and potentially positioning the company for broader scale-up.
If the Proactive Care service demonstrates measurable reductions in avoidable hospitalizations and improved patient outcomes, it could support a stronger economic case for remote monitoring solutions in COPD and other chronic conditions. That, in turn, could improve Doccla’s prospects for recurring revenue from long-term contracts with health systems and reinforce its competitive position in the digital health and virtual care market.